BECTON DICKINSON & CO
DEF 14A, 1994-01-05
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: ALGER FUND, NSAR-B, 1994-01-05
Next: BOISE CASCADE CORP, 424B3, 1994-01-05



<PAGE>
     
                           SCHEDULE 14A INFORMATION     
 
  PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF
                                      1934
 
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
 
Check the appropriate box:
     
[ ] Preliminary Proxy Statement
[X] Definitive Proxy Statement 
[X] Definitive Additional Materials     
[ ] Soliciting Material Pursuant to (S)240.14a-11(c) or (S)240.14a-12
 
                         BECTON, DICKINSON AND COMPANY
                (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
                         BECTON, DICKINSON AND COMPANY
                   (NAME OF PERSON(S) FILING PROXY STATEMENT)
 
Payment of Filing Fee (Check the appropriate box):
 
[X] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), or 14a-6(j)(2).
[ ] $500 per each party to the controversy pursuant to Exchange Act Rule 14a-
    6(i)(3).
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
 
  1) Title of each class of securities to which transaction applies:
 
  _____________________________________________________________________________
  2) Aggregate number of securities to which transaction applies:
 
  _____________________________________________________________________________
  3) Per unit price or other underlying value of transaction computed pursuant
     to Exchange Act Rule 0-11:
 
  _____________________________________________________________________________
  4) Proposed maximum aggregate value of transaction:
 
  _____________________________________________________________________________
[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
  0-11(a)(2) and identify the filing for which the offsetting fee was paid
  previously. Identify the previous filing by registration statement number, or
  the Form of Schedule and the date of its filing.
 
  1) Amount Previously Paid:
 
  _____________________________________________________________________________
  2) Form, Schedule or Registration Statement No.:
 
  _____________________________________________________________________________
  3) Filing Party:
 
  _____________________________________________________________________________
  4) Date Filed:
 
  _____________________________________________________________________________

<PAGE>
 
     
     
   RAYMOND V. GILMARTIN                          BECTON DICKINSON AND COMPANY
   Chairman of the Board                         1 Becton Drive
                                                 Franklin Lakes, New Jersey
                                                 07417-1880
 
LOGO
 
                                                                 January 5, 1994
 
To Our Shareholders:
 
  You are cordially invited to attend the Annual Meeting of Shareholders of
Becton, Dickinson and Company scheduled for 2:30 p.m. on Tuesday, February 8,
1994 at the Marriott Hotel in Saddle Brook, New Jersey.
 
  The matters expected to be acted upon at the meeting are described in detail
in the attached Notice of Meeting and Proxy Statement.
 
  It is important that your shares be represented at the meeting. Whether or
not you plan to attend personally, please complete and mail the enclosed proxy
card in the enclosed return envelope.
 
                            Sincerely,
 
                            /s/ RAYMOND V. GILMARTIN
 
                            Raymond V. Gilmartin
                            Chairman of the Board
<PAGE>
 
     
     
                    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
 
                                       OF
 
                         BECTON, DICKINSON AND COMPANY
                                 1 BECTON DRIVE
                     FRANKLIN LAKES, NEW JERSEY 07417-1880
 
                               ----------------
 
  The Annual Meeting of Shareholders of BECTON, DICKINSON AND COMPANY will be
held at the Marriott Hotel, Garden State Parkway at Interstate 80, Saddle
Brook, New Jersey on Tuesday, February 8, 1994, at 2:30 P.M. to act upon the
following proposals:
 
  1.  Election of three directors to terms of three years.
 
  2.  Approval of the selection of independent auditors.
 
  3.  Approval of the 1994 Restricted Stock Plan for Non-Employee Directors.
 
  4.  A shareholder proposal relating to the disclosure of political
      contributions.
 
  5.  Such other business as may properly come before the meeting.
 
  Only shareholders of record at the close of business on December 13, 1993
will be entitled to vote at this meeting.
 
                                              By order of the Board of
                                              Directors,
 
                                                /s/ RAYMOND P. OHLMULLER
 
                                                    Raymond P. Ohlmuller
                                                Vice President and Secretary
 
Dated: January 5, 1994
<PAGE>
                                         
                                             
 
                                PROXY STATEMENT
 
                               ----------------
 
                         BECTON, DICKINSON AND COMPANY
                                 1 BECTON DRIVE
                     FRANKLIN LAKES, NEW JERSEY 07417-1880
 
                               ----------------
 
                              GENERAL INFORMATION
 
  The enclosed proxy/voting instruction card ("proxy") is solicited by the
Board of Directors of Becton, Dickinson and Company for the Annual Meeting of
Shareholders to be held at the Marriott Hotel, Garden State Parkway at
Interstate 80, Saddle Brook, New Jersey on Tuesday, February 8, 1994, at 2:30
P.M. A proxy may be revoked at any time before it is voted by sending written
notice of revocation to the Secretary of the Company, by executing a proxy
bearing a later date or by voting in person at the meeting. The proxy and this
proxy statement are being mailed to shareholders on or about January 5, 1994.
 
  On December 13, 1993, the record date for determining shareholders entitled
to notice of and to vote at the meeting, there were 73,516,975 shares of the
Company's Common Stock (the "Common Stock") outstanding, each entitled to one
vote. In addition, on December 13, 1993 there were 981,382 shares of the
Company's Series B ESOP Convertible Preferred Stock (the "ESOP Preferred
Stock") outstanding, all of which are held by State Street Bank and Trust
Company, as Trustee of the Company's Savings Incentive Plan. The shares of ESOP
Preferred Stock are entitled to vote on all matters submitted to a vote of the
Company's shareholders and also carry one vote per share. Each employee
participating in the Savings Incentive Plan is entitled to instruct the Trustee
how to vote all shares of Common Stock and ESOP Preferred Stock allocated to
that employee's Savings Incentive Plan accounts. The enclosed proxy will serve
as voting instructions to the Trustee from Savings Incentive Plan participants.
Shares of each class of stock held in the Savings Incentive Plan for which
voting instructions are not received from Savings Incentive Plan participants
or which are not allocated to participants' accounts are voted by the Trustee
in the same proportion as shares of that class for which the Trustee has
received instructions.
 
  Proxies representing shares of Common Stock held of record will also
represent shares held under the Company's Automatic Dividend Reinvestment Plan
and, in addition, will vote shares of Common Stock and ESOP Preferred Stock
allocated to employees' accounts under the Company's Savings Incentive Plan, if
the registrations are the same. Separate mailings will be made for shares not
held under the same registrations.
 
  Directors are elected by a plurality of the votes cast at the meeting. The
approval of Proposals 2 and 4 each requires the affirmative vote of a majority
of the votes cast. Adoption of Proposal 3 requires the affirmative vote of a
majority of the shares present or represented by proxy at the meeting that are
entitled to vote. Since directors are elected by a plurality, abstentions and
broker non-votes will not have an impact on their election. Abstentions and
broker non-votes will not be counted in tabulating the number of votes cast on
Proposals 2 and 4, but will have the effect of votes cast against Proposal 3.
 
  The Board of Directors is not aware of any matters to be presented at the
meeting other than those set forth in the accompanying notice. If any other
matters properly come before the meeting, the persons named in the proxy will
vote in accordance with their best judgment.
<PAGE>
 
  In addition to solicitation by mail, directors, officers and other employees
of the Company may solicit proxies personally, by telephone or by telegram.
Brokers and other nominees will be requested to solicit proxies or
authorizations from beneficial owners and will be reimbursed for their
reasonable expenses in doing so. The Company has retained Hill and Knowlton,
Inc. to assist in soliciting proxies for a fee not to exceed $12,500 plus
expenses. The cost of soliciting proxies will be borne by the Company.
 
                              SHARE OWNERSHIP OF
                   MANAGEMENT AND CERTAIN BENEFICIAL OWNERS
 
  According to CDA Investment Technologies, Inc., a firm that monitors
institutional share ownership, as of September 30, 1993 Oppenheimer & Co.,
L.P., World Financial Center, New York, New York 10281, was the beneficial
owner of 12,402,991 shares of Common Stock, constituting 16.9% of the
outstanding Common Stock, and Cooke & Bieler Inc., 1700 Market Street,
Philadelphia, Pennsylvania 19103, was the beneficial owner of 5,563,300 shares
of Common Stock, constituting 7.6% of the outstanding Common Stock. No changes
in these holdings have come to the Company's attention since then. The Company
is not aware of any other beneficial owner of more than 5% of its Common
Stock.
 
  The following tables set forth, as of October 31, 1993, information
concerning the beneficial ownership of Common Stock and ESOP Preferred Stock
by each director and nominee for director, each of the Company's executive
officers, and all directors and executive officers as a group, and the
beneficial owner of more than 5% of the outstanding ESOP Preferred Stock. No
director or executive officer owns more than 1% of the outstanding Common
Stock except Wesley J. Howe, who, including shares which may be acquired by
him within 60 days, is the beneficial owner of 1.3% of the Common Stock. All
directors and executive officers as a group are the beneficial owners of 3.1%
of the Common Stock, including shares which may be acquired by them within 60
days.
 
                                 COMMON STOCK
 
<TABLE>
<CAPTION>
                                                 SHARES OWNED    SHARES WHICH
                                                 DIRECTLY AND   MAY BE ACQUIRED
                        NAME                     INDIRECTLY(1) WITHIN 60 DAYS(2)
                        ----                     ------------- -----------------
      <S>                                        <C>           <C>
      Harry N. Beaty...........................       2,000                0
      Henry P. Becton, Jr. ....................      40,030(3)             0
      Clateo Castellini........................      12,100          184,000
      Gerald M. Edelman........................       1,490                0
      Edmund B. Fitzgerald.....................       1,600                0
      John W. Galiardo.........................      37,679          172,600
      Raymond V. Gilmartin.....................      64,683          421,800
      Richard W. Hanselman.....................       4,000                0
      Thomas A. Holmes.........................      10,318                0
      Wesley J. Howe...........................     541,910          385,000
      William B. Macomber......................       2,145                0
      Walter M. Miller.........................      25,785          154,738
      Frank A. Olson...........................       5,000                0
      Robert A. Reynolds.......................      18,263          144,000
      Gloria M. Shatto.........................       1,700                0
      Raymond S. Troubh........................      25,000(4)             0
      All Directors and Executive Officers as a
       group (16 persons)......................     793,703        1,462,138
</TABLE>
- --------
  (1) Includes Common Stock allocated to individual accounts under the Savings
     Incentive Plan as follows: Mr. Castellini, 1,985 shares, Mr. Galiardo
     4,107 shares, Mr. Gilmartin, 4,605 shares, Mr. Miller, 2,264 shares, Mr.
     Reynolds, 3,852 shares; and all directors and executive officers as a
     group, 16,813 shares.
 
                                       2
<PAGE>
 
  (2) Includes stock options available for exercise and shares to be
distributed under the Company's Stock Award Plan within 60 days.
 
  (3) Includes 27,030 shares held by a trust of which Mr. Becton is a co-
trustee with shared investment and voting power and 13,000 shares held by a
corporation owned by the trust. Does not include 7,700 shares owned by Mr.
Becton's wife, 400 shares owned by a daughter or 20,660 shares held in trusts
for the benefit of his children, as to which he disclaims beneficial
ownership.
 
  (4) Does not include 10,000 shares owned by Mr. Troubh's wife, as to which
he disclaims beneficial ownership.
 
                             ESOP PREFERRED STOCK
 
<TABLE>
<CAPTION>
                                                                   SHARES OWNED
                                                                   DIRECTLY AND
                                                                    INDIRECTLY
                                                                   ------------
      <S>                                                          <C>
      Clateo Castellini...........................................      287(1)
      John W. Galiardo............................................      271(1)
      Raymond V. Gilmartin........................................      281(1)
      Walter M. Miller............................................      280(1)
      Robert A. Reynolds..........................................      241(1)
      All Directors and Executive Officers as a group (16 per-
       sons)......................................................    1,360(1)
      State Street Bank and Trust Company.........................  983,500(2)
       225 Franklin Street
       Boston, Massachusetts 02110
       (as Trustee of the Savings Incentive Plan)
</TABLE>
- --------
  (1) Shares allocated to individual accounts under the ESOP component of the
Savings Incentive Plan. Such shares constitute less than 1% of the total
beneficial ownership of the ESOP Preferred Stock.
 
  (2) Constitutes 100% of the outstanding shares of ESOP Preferred Stock.
 
COMPLIANCE WITH SECTION 16(A) OF THE SECURITIES EXCHANGE ACT OF 1934
 
  Section 16(a) of the Securities Exchange Act of 1934 requires the Company's
executive officers and directors to file initial reports of their ownership of
the Company's equity securities and reports of changes in such ownership with
the Securities and Exchange Commission (the "SEC") and the New York Stock
Exchange. Executive officers and directors are required by SEC regulations to
furnish the Company with copies of all Section 16(a) forms they file. Based
solely on a review of the copies of such forms and written representations
from the Company's executive officers and directors, the Company believes that
for the period from October 1, 1992 through September 30, 1993, all of its
executive officers and directors were in compliance with the disclosure
requirements of Section 16(a), except that one transaction involving a gift
was inadvertently reported 15 days late by Henry P. Becton, Jr., a director of
the Company.
 
                              BOARD OF DIRECTORS
 
MEETINGS; CERTAIN COMMITTEES
 
  The Board of Directors, which held seven meetings during the fiscal year
ended September 30, 1993, has seven standing committees, including the Audit
Committee, the Corporate Responsibility Committee, the Compensation and
Benefits Committee and the Committee on Directors, which serves as a
nominating committee. All directors attended more than 75 percent of the
aggregate of the total number of meetings of the Board and the committees on
which each director served, except for Wesley J. Howe, who did not do so due
to poor health.
 
  The Audit Committee reviews and discusses the plan and results of the annual
audit with the Company's independent and internal auditors and approves non-
audit services provided by the independent auditors. This Committee also
reviews the Company's internal auditing, control and accounting systems. In
addition, this Committee makes recommendations to the Board concerning the
selection of independent auditors. The members of this Committee, which met
three times during the year, are Henry P. Becton, Jr., Chairman, Harry N.
Beaty, Gerald M. Edelman, William B. Macomber, Frank A. Olson and Raymond S.
Troubh.
 
                                       3
<PAGE>
 
  The Corporate Responsibility Committee reviews the Company's policies and
procedures affecting its role as a responsible corporate citizen, including
those relating to issues such as equal employment opportunity and community
relations, to health, safety and environmental matters, and to proper business
practices. The members of this Committee, which met once during the year, are
Gerald M. Edelman, Chairman, Harry N. Beaty, Edmund B. Fitzgerald, Raymond V.
Gilmartin, William B. Macomber and Gloria M. Shatto.
 
  The Compensation and Benefits Committee fixes the compensation of corporate
officers and approves any employment or consulting contracts with corporate
officers who are not also directors. This Committee also reviews and makes
recommendations to the Board concerning proposed contracts with directors. In
addition, it administers the Company's stock option plans and the Stock Award
Plan. This Committee also oversees the administration of employee benefits and
benefit plans for the Company. The members of this Committee, which met four
times during the year, are Thomas A. Holmes, Chairman, Edmund B. Fitzgerald,
Richard W. Hanselman, Frank A. Olson and Raymond S. Troubh.
 
  The Committee on Directors recommends candidates for election as directors to
the Board. It also reviews and makes recommendations concerning the
composition, organization and function of the Board and its committees, as well
as on the performance and compensation of directors. The members of this
Committee, which met twice during the year, are Richard W. Hanselman, Chairman,
Henry P. Becton, Jr., Raymond V. Gilmartin, Thomas A. Holmes, Wesley J. Howe
and William B. Macomber.
 
  Any shareholder may recommend nominees for director to the Committee on
Directors by writing to the Secretary of the Company. Submissions should
include the full name and address and a statement of the qualifications of the
proposed nominee.
 
DIRECTORS' FEES
 
  Each director who is not employed by the Company receives an annual retainer
of $40,000 for Board service plus attendance fees of $1,000 for special
meetings of the Board and $650 for committee meetings. An annual retainer of
$2,000 is also paid to committee chairmen. Directors may defer all or part of
their annual retainers until they retire from the Board or their principal
occupations. In addition, Gerald M. Edelman was engaged by the Company during
the fiscal year as a consultant in the fields of cell biology and solid tissue
diagnostics. The Company paid Dr. Edelman a fee of $50,000 for his consulting
services.
 
  After resignation or retirement from the Board, a qualifying director is
eligible to serve as a consultant for a term equal to his or her service on the
Board at an annual fee equal to the retainer paid to active non-employee
directors. To qualify, a director must serve on the Board for five years, and,
if employed by the Company, must either continue as an employee and a director
until age 60, unless termination of employment is by reason of disability, or
be reelected a director by the shareholders after termination of employment.
 
                                       4
<PAGE>
 
PROPOSAL 1.                  ELECTION OF DIRECTORS
 
  The Board of Directors is divided into three classes, the terms of which
expire alternately over a three-year period. The Board proposes the election of
three directors to serve for three years until the 1997 Annual Meeting and
until their successors have been elected and have qualified. The candidates,
Harry N. Beaty, Raymond V. Gilmartin and Frank A. Olson, are incumbent
directors who were elected to their present terms by the shareholders.
 
NOMINEES FOR DIRECTOR--TERM TO EXPIRE 1997
 
 
      (ART)          Harry N. Beaty, M.D., 61, has been a director since 1985.
                     He is a Professor of Medicine and Dean of the
                     Northwestern University Medical School. Dr. Beaty is a
                     specialist in internal medicine and a subspecialist in
                     infectious diseases. He is a director of HealthTrust,
                     Inc.
 

 
 
      (ART)          Raymond V. Gilmartin, 52, has been a director since 1984,
                     Chairman of the Board since November 1992, Chief
                     Executive Officer since 1989 and President since 1987.
                     Mr. Gilmartin is a director of Capital Holding Corp. and
                     Public Service Enterprise Group Inc.
 
 
 
      (ART)          Frank A. Olson, 61, has been a director since 1985. He is
                     Chairman of the Board and Chief Executive Officer of The
                     Hertz Corporation, a transportation company. Mr. Olson is
                     a director of Cooper Industries, Inc., Commonwealth
                     Edison Co., The Hertz Corporation and UAL Corporation.
 
 
 
                                       5
<PAGE>
 
                              CONTINUING DIRECTORS
 
  The directors listed below were elected by the shareholders to terms expiring
in 1995 and 1996, respectively, and will continue to serve.
 
TERM TO EXPIRE 1995
                        
      (ART)          Henry P. Becton, Jr., 50, has been a director since 1987.
                     He is President and General Manager of WGBH Educational
                     Foundation. WGBH is a producer and broadcaster of public
                     television and radio programs. It also produces books and
                     other educational materials. Mr. Becton is a director of
                     various Scudder mutual funds.     
 
 
 
      (ART)          Gerald M. Edelman, M.D., Ph.D., 64, has been a director
                     since 1982. He is a Member of the Scripps Research
                     Institute, Chairman of its Department of Neurobiology,
                     and Director of The Neurosciences Institute. His research
                     is concerned with the developmental biology of the brain.
                     Dr. Edelman is a director of General American Investors
                     Co., Inc.
 

 
      (ART)          Edmund B. Fitzgerald, 67, has been a director since 1990.
                     He is an Adjunct Professor at the Owen Graduate School of
                     Management at Vanderbilt University. Previously, he was
                     Chairman of the Board and Chief Executive Officer of
                     Northern Telecom Ltd., a manufacturer of digital
                     telecommunications equipment, from 1985 to 1990 and
                     President from 1982 to 1985. He is a director of Northern
                     Telecom Ltd., Ashland Oil, Inc. and GTI Corp.
 

                        
      (ART)          Richard W. Hanselman, 66, has been a director since 1981.
                     He is a corporate director. Mr. Hanselman was Chairman of
                     the Board, President and Chief Executive Officer of
                     Genesco, Inc., a diversified manufacturer of footwear and
                     apparel, prior to 1986. Mr. Hanselman is a director of
                     Arvin Industries, Inc., Bradford Funds, Inc., Foundation
                     Health Corp., Gryphon Holdings Inc., HealthTrust, Inc.
                     and IMCO Recycling, Inc.     
 
 
 
                                       6
<PAGE>
 
TERM TO EXPIRE 1996
 
      (ART)          Thomas A. Holmes, 70, has been a director since 1986.
                     Prior to his retirement in 1988, Mr. Holmes was Chairman
                     of the Board, President and Chief Executive Officer of
                     Ingersoll-Rand Company, a manufacturer of industrial
                     machinery and related products. He is a director of Arvin
                     Industries, Inc., W.R. Grace & Co., Newmont Gold Co. and
                     Newmont Mining Corp.
 
 
      (ART)          Gloria M. Shatto, 62, has been a director since 1986. She
                     is President of Berry College. She is a director of
                     Georgia Power Co., K Mart Corp., The Southern Company and
                     Texas Instruments Inc.
 
 
      (ART)          Raymond S. Troubh, 67, has been a director since 1977. He
                     is a financial consultant and Senior Advisor to Salomon
                     Brothers, Inc. Mr. Troubh is a director of ADT Ltd.,
                     American Maize-Products Co., Applied Power Inc., Benson
                     Eyecare Corp., Foundation Health Corp., General American
                     Investors Co., Inc., Manville Corp., Olsten Corp.,
                     Riverwood International Corp., Time Warner, Inc. and
                     Wheeling-Pittsburgh Corp.
 
      
 
 
 
                             EXECUTIVE COMPENSATION
      
 
 
               REPORT OF THE COMPENSATION AND BENEFITS COMMITTEE
                           ON EXECUTIVE COMPENSATION
 
  The compensation of the Company's executive officers is determined by the
Compensation and Benefits Committee of the Board of Directors. The Committee
has five members, each of whom is a non-employee director independent of
management. No member of the Committee has any insider or interlocking
relationship with the Company, as these terms are defined in applicable rules
and regulations of the SEC.
 
COMPENSATION PHILOSOPHY
 
  The Company's executive compensation philosophy is to align the interests of
executive management with shareholder interests through compensation programs
linked to growth in shareholder value, principally measured by stock price
performance. The Committee determines a total compensation structure for each
executive officer, including the Chief Executive Officer, Mr. Gilmartin,
 
                                       7
<PAGE>
 
focused primarily upon base salary, annual incentive bonus and stock options.
Base salary levels and annual incentive bonus targets are set to approximate
median levels expected for companies of comparable size and business activity.
Stock option grant levels and terms are established to provide opportunity for
compensation levels at the higher end of the range for comparable positions in
the marketplace, if management is successful in achieving long-term growth in
shareholder value. As a consequence, compensation packages for the Company's
executive officers are more heavily weighted toward performance-based
compensation (stock options plus annual incentive bonuses) than the norm.
 
  Compensation decisions are supported by analysis of published surveys and
periodic special studies. Primary emphasis is placed upon prevailing practice
by medical products manufacturing and technology companies, taking account of
differentials in company size; considerable weight is also given to the general
practice in U.S. industry among companies of comparable size.
 
PRINCIPAL COMPENSATION ELEMENTS
 
  The principal elements of executive compensation at the Company are base
salary, annual incentive bonus, and stock options.
 
  BASE SALARY levels are reviewed annually, and adjusted as appropriate to
reflect market position and individual performance. Base salaries for Mr.
Gilmartin and the other executive officers are set to approximate median levels
for executives with similar roles and responsibilities in companies of
comparable size, industry and complexity.
 
  ANNUAL INCENTIVE BONUSES are awarded annually under the Company's Executive
Bonus Plan. Bonus targets are set to approximate median levels for executives
with similar roles and responsibilities in comparable companies. Annual bonus
awards for each of the Company's executive officers are approved by the
Committee. The Executive Bonus Plan sets forth specific formulas and factors to
be used in assessing each executive officer's financial and strategic
performance during the fiscal year for purposes of determining his annual award
under the Executive Bonus Plan. These factors stress annual performance in
achieving earnings levels that meet or exceed annual budgets, and concrete
accomplishments in improving the Company's competitive position.
 
  Bonus awards for Messrs. Gilmartin, Galiardo and Reynolds are based
principally (75%) upon the Company's reported earnings per share compared to
annual growth targets established in concurrence with the Board. Additional
weight (25%) is given to each individual's specific accomplishments during the
year toward achieving the Company's long-term strategic objectives. Bonus
awards for Messrs. Castellini and Miller are based principally (50%) upon the
operating income generated by their respective business Sectors compared to
targets incorporated in the annual budget approved by the Board. Additional
weight (25%) is given to the Company's overall earnings per share performance
and to strategic accomplishments (25%). In all cases, there are minimum
thresholds of overall Company (and, where applicable, Sector) financial
performance that must be achieved before any bonus is paid for a particular
fiscal year.
 
  STOCK OPTIONS are awarded each year by the Committee to executive officers in
accordance with the Company's 1990 Stock Option Plan, as applied to the
executive officers through the SENIOR EXECUTIVE OPTION POLICY adopted by the
Committee in May 1990. THE SENIOR EXECUTIVE OPTION POLICY established an
indexed stock option program intended to compensate executive officers both for
absolute growth in shareholder value and for relative Company Common Stock
price performance compared to the performance of the "Standard and Poor's 500
Composite Stock Price Index" (the "S&P 500 Index").
 
                                       8
<PAGE>
 
  The Committee believes this program for annual option grants to the executive
officers provides a strong incentive to achieve a pattern of sustainable
performance which increases shareholder value and to surpass the average return
available to investors as represented by the S&P 500 Index. As a part of this
program, the executive officers are no longer eligible for grants under the
Company's Stock Award Plan, and have not received any grants under that Plan
since 1990.
 
  This stock option program provides for the annual grant through 1994 to each
of the executive officers of a specified minimum number of nonqualified options
with exercise prices which are to be indexed to the change from May 21, 1990 in
the S&P 500 Index. On that date, the mean of the high and low of the Company's
Common Stock price (the "fair market value") was $31.565 and the S&P 500 Index
closed at 358.00. To the extent that changes in the per share price of the
Company's Common Stock from that date outperform the S&P 500 Index, the
exercise price of future option grants would be set at a discount from the
Common Stock's fair market value on the date of grant. Conversely, to the
extent the Company's Common Stock does not perform as well as the S&P 500
Index, such future grants would have an exercise price greater than the fair
market value of the Company's Common Stock on the date of each grant.
 
  Each annual grant is exercisable for a period of ten years from the date of
grant. The maximum potential value of each grant will be realized by achieving
sustained favorable Company performance throughout this period and by deferring
exercise until the latter portion of the ten-year exercise period.
 
  The following table summarizes the relative performance of the S&P 500 Index
and the Company's per-share price since the inception of this policy in May
1990, and the impact upon stock option grant price levels for the 1991, 1992
and 1993 grants. On May 24, 1993, the executive officers were granted options
at an exercise price of $39.50 per share, which was above the $37.25 per share
fair market value on that date. This premium over the current market price
creates an additional incentive to achieve stock price growth in the future.
 
<TABLE>
<CAPTION>
                                                (5/21)  (5/21)  (5/19)   (5/24)
                                                 1990    1991    1992     1993
                                                ------- ------- -------  ------
<S>                                             <C>     <C>     <C>      <C>
S&P 500 Index.................................. 358.00  375.35  416.37   448.00
Company Per-Share Market Value................. $31.565 $38.78  $35.845  $37.25
Senior Executive Option Policy
  Grant Price.................................. $31.565 $33.095 $36.71   $39.50
Discount/(Premium).............................   -0-   $ 5.685 $(0.865) $(2.25)
</TABLE>
 
1993 COMPENSATION ACTIONS: MR. GILMARTIN
 
  Mr. Gilmartin participates in the same executive compensation programs
provided to the other executive officers. His compensation targets and mix are
even more heavily weighted towards performance-based compensation, specifically
annual incentive bonus and indexed stock options, to emphasize the link between
changes in shareholder value and his compensation as Chief Executive Officer.
 
  During the past year Mr. Gilmartin was elected by the Board to the additional
post of Chairman of the Board, upon the retirement of Wesley J. Howe. He
retained his other positions of Chief Executive Officer and President. The
Committee has adjusted Mr. Gilmartin's base salary and target bonus under the
Executive Bonus Plan to a level it considers to be at the median of the market
compensation for individuals serving as Chairman and Chief Executive Officer in
companies of comparable size, industry and complexity.
 
  Mr. Gilmartin received an award of 60,000 stock options in May 1993 in
accordance with the Senior Executive Option Policy. The Company believes that
these options represent the most valuable
 
                                       9
<PAGE>
 
component of his compensation, and they are the exclusive vehicle now used to
award long-term compensation to Mr. Gilmartin. By relying solely upon stock
option grants indexed to the performance of the S&P 500, the Committee believes
it is providing Mr. Gilmartin significant incentive to take actions to achieve
sustained, long-term increases in shareholder value that are superior to the
average performance of the market.
 
  The Committee authorized an annual incentive bonus award of $420,000 for Mr.
Gilmartin for fiscal 1993, which represents a full target award. In the
Committee's judgment, the Company's earnings per share performance was
consistent with budget expectations, and overall strategic accomplishments were
in accordance with the Company's business plan.
 
1993 COMPENSATION ACTIONS: OTHER EXECUTIVE OFFICERS
 
  Indexed stock options under the Senior Executive Option Policy are the most
significant element of compensation for the Company's executive officers.
During fiscal 1993, each of the executive officers received an additional grant
consistent with the terms of this program. This is the exclusive vehicle used
to award long-term compensation to this group.
 
  Over the past few years each of the executive officers has received salary
adjustments to bring his base salary level in line with median market practice
for executives with similar responsibilities in companies of comparable size,
industry and complexity. The Committee believes this level has been
substantially achieved with the salary increases (average increase 5%) that
were approved and took effect for the executive officers during the fiscal
year.
 
  The Committee authorized annual incentive bonus awards for the executive
officers that ranged from zero to 110% of target. In one case, financial
performance versus budget was below the threshold level required. The other
awards, all of which exceeded target, reflected financial performance
consistent with the applicable budget and significant strategic
accomplishments.
 
  The tables and graphs following this report set forth information on the
compensation for the Company's five executive officers (the "named
executives").
 
                      COMPENSATION AND BENEFITS COMMITTEE
 
THOMAS A. HOLMES, CHAIRMAN
 
EDMUND B. FITZGERALD                      RICHARD W. HANSELMAN
 
FRANK A. OLSON                            RAYMOND S. TROUBH
 
                                       10
<PAGE>
 
COMPENSATION OF NAMED EXECUTIVES
 
 GENERAL
 
  The following table shows, for the fiscal years ended September 30, 1991,
1992 and 1993, compensation provided by the Company to each of the named
executives in all capacities in which they served.
 
                          SUMMARY COMPENSATION TABLE
 
<TABLE>
<CAPTION>
                                                                           LONG TERM
                                                                         COMPENSATION
                                                                     ---------------------
                                    ANNUAL COMPENSATION                     AWARDS
                        -------------------------------------------- ---------------------
                                                        OTHER        RESTRICTED
NAME AND                FISCAL                          ANNUAL         STOCK     OPTIONS/      ALL OTHER
PRINCIPAL POSITION       YEAR  SALARY(A) BONUS(A) COMPENSATION(B)(C) AWARDS(D)  SARS(D)(E) COMPENSATION(B)(F)
- ------------------      ------ --------- -------- ------------------ ---------- ---------- ------------------
<S>                     <C>    <C>       <C>      <C>                <C>        <C>        <C>
Raymond V. Gilmartin     1993  $629,167  $420,000         0               0       60,000        $29,388
President and Chief      1992   575,000   250,000        --               0       60,000            --
Executive Officer        1991   515,000   240,000        --               0       60,000            --

Clateo Castellini        1993   312,500   165,000         0               0       36,000         21,086
Sector President--       1992   285,000   100,000        --               0       36,000            --
Medical                  1991   255,000    95,000        --               0       36,000            --

John W. Galiardo         1993   271,083   115,000         0               0       30,000         18,738
Vice President and       1992   255,333    93,000        --               0       30,000            --
General Counsel          1991   235,667    83,000        --               0       30,000            --

Walter M. Miller         1993   302,500         0         0               0       36,000          6,891
Sector President--       1992   270,833    90,000        --               0       36,000            --
Diagnostic               1991   240,000    84,000        --               0       36,000            --

Robert A. Reynolds       1993   245,000   105,000         0               0       30,000         16,171
Vice President--         1992   226,667    85,000        --               0       30,000            --
Finance and Controller   1991   206,667    75,000        --               0       30,000            --
</TABLE>
- --------
(A) Amounts shown reflect salary and bonuses earned by the named executives
    for the applicable fiscal year. Bonuses are paid in the fiscal year
    following the fiscal year for which they are earned, unless deferred at
    the election of the executive.
(B) Information for fiscal years ending prior to December 15, 1992 has been
    omitted in accordance with the rules and regulations of the SEC.
(C) None of the named executives received perquisites and other personal
    benefits exceeding the lesser of $50,000 or 10% of each named executive's
    annual salary and bonus.
(D) The named executives have not been eligible for further awards under the
    Company's Stock Award Plan since the adoption of the Senior Executive
    Option Policy in May 1990. The following table contains information
    relating to the outstanding holdings of restricted stock of the named
    executives, which all relate to undistributed portions of awards granted
    under the Stock Award Plan in 1990 and preceding years.
 
<TABLE>
<CAPTION>
                                                     CURRENT MARKET
                                          NUMBER OF     VALUE OF
                                         RESTRICTED    RESTRICTED
        NAME                             SHARES HELD  SHARES HELD
        ----                             ----------- --------------
        <S>                              <C>         <C>
        Raymond V. Gilmartin............   19,502       $733,763
        Clateo Castellini...............   11,458        431,107
        John W. Galiardo................   10,602        398,900
        Walter M. Miller................    8,264        310,933
        Robert A. Reynolds..............   17,842        671,305
</TABLE>
 
  Under the terms of the Stock Award Plan, most of these holdings (stated as a
  percentage of each named executive's total holdings) may not be distributed
  until retirement or termination of employment: 15,602 (80%) for Mr.
  Gilmartin; 9,978 (87%) for Mr. Castellini; 9,252 (87%) for Mr. Galiardo;
  6,704 (81%) for Mr. Miller; and 16,612 (93%) for Mr. Reynolds.
 
  Values are determined by multiplying the number of undistributed shares by
  $37.625, the September 30, 1993 closing price for the Company's Common
  Stock. No discount has been taken to reflect (1) the continuing restrictions
  on distribution and transferability, or (2) the fact that undistributed
  shares are not dividend-bearing.
 
 
                                      11
<PAGE>
 
(E) All option grants shown are awarded in accordance with the Senior
    Executive Option Policy described above. As a result, each option grant
    reflects a discount (or premium) to current market value, depending upon
    the Company's cumulative share price growth compared to the S&P 500 Index,
    as follows:
 
    1993 ($2.25) per share premium
 
    1992 ($0.865) per share premium
 
    1991 $5.685 per share discount
 
(F) Amounts shown represent the sum of (1) the Company's matching
    contributions to the Company's Savings Incentive Plan, a qualified defined
    contribution plan available to U.S. employees at all levels, and (2) the
    dollar value of split-dollar life insurance policies provided for each of
    the named executives.
 
  During the fiscal year the Company made contributions to the Savings
  Incentive Plan of $7,075 for Mr. Gilmartin, $6,624 for Mr. Castellini,
  $7,019 for Mr. Galiardo, $6,891 for Mr. Miller, and $7,258 for Mr. Reynolds.
  These amounts represent Company matching contributions at a 50% rate of the
  first 6% of base pay contributed to the Plan by each of the named
  executives, in accordance with applicable Plan rules and subject to limits
  imposed by the Internal Revenue Code upon maximum contributions to such tax-
  qualified plans.
 
  The Company has made a split-dollar life insurance policy available to the
  named executives in lieu of full participation in the Company's group life
  insurance program. The death benefit payable to the beneficiary of an
  insured named executive is two times that executive's base salary. Under
  this split-dollar arrangement, the premiums are paid by the Company in a
  fixed time period during the initial years in which the policies are in
  effect. If assumptions about mortality, dividends and other factors are
  realized, the Company will recover all of its payments for premiums from the
  cash value of the policy at the later of a designated period or retirement
  of the named executive. Full ownership of the policy will be transferred to
  the named executive at that time. The premiums paid on behalf of each named
  executive during fiscal 1993 have been prorated to reflect the current value
  of term life insurance coverage for the fiscal year plus the deferred
  reimbursement to the Company of the premium payments. The compensatory
  portion of the premium payments for each named executive during the year was
  $22,313 for Mr. Gilmartin, $14,462 for Mr. Castellini, $11,719 for Mr.
  Galiardo, $0 for Mr. Miller, and $8,913 for Mr. Reynolds.
 
STOCK OPTION GRANTS
 
  The following table contains information relating to stock option grants and
tandem stock appreciation rights ("SARs") made in fiscal 1993 under the
Company's 1990 Stock Option Plan and the Senior Executive Option Policy
described above.
 
                           OPTION/SAR GRANTS IN 1993
 
<TABLE>
<CAPTION>
                            INDIVIDUAL GRANTS
                          ----------------------
                                     % OF TOTAL
                                    OPTIONS/SARS                      GRANT
                          OPTIONS/   GRANTED TO                       DATE
                            SARS    EMPLOYEES IN EXERCISE  EXPIRATION PRESENT
    NAME                  GRANT (A) FISCAL YEAR  PRICE (B)    DATE    VALUE (C)
    ----                  --------- ------------ --------- ---------- ---------
<S>                       <C>       <C>          <C>       <C>        <C>
Raymond V. Gilmartin.....    60,000      5.7%     $39.50    5/23/03   $757,200
Clateo Castellini........    36,000      3.4%      39.50    5/23/03    454,320
John W. Galiardo.........    30,000      2.8%      39.50    5/23/03    378,600
Walter M. Miller.........    36,000      3.4%      39.50    5/23/03    454,320
Robert A. Reynolds.......    30,000      2.8%      39.50    5/23/03    378,600
                          ---------    ------
TOTAL....................   192,000     18.1%       N.A.       N.A.       N.A.
All Optionees............ 1,054,764    100.0%      38.41    5/23/03       N.A.
</TABLE>
- --------
(A) All option grants to the named executives are for a ten-year term. They
    are exercisable immediately, subject to applicable rules and regulations
    of the SEC. These option grants are issued in tandem with limited SARs,
    exercisable only in the event of a tender offer for the Company's Common
    Stock or a change in control of the Company, as defined under the
    Company's 1990 Stock Option Plan.
 
(B) Option grants to the named executives are in accordance with the terms of
    the Senior Executive Option Policy described above. The exercise price of
    $39.50 represents a premium of $2.25 over the fair market value of Company
    Common Stock on May 24, 1993 (the date of the grant).
 
  During the fiscal year the Company awarded 862,764 option grants to other
  participants in its stock option programs as follows: 136,220 on May 24,
  1993 at an exercise price of $37.25 and 726,544 on January 25, 1993 at an
  exercise price of $38.625. The weighted average exercise price of these
  grants is $38.41.
 
                                      12
<PAGE>
 
(C) This estimate of value has been developed solely for purposes of
    comparative disclosure in accordance with the rules and regulations of the
    SEC, and does not necessarily reflect the Company's view of the
    appropriate value or methodology for purposes of financial reporting. The
    estimated value has been determined by application of the Black-Scholes
    option pricing model, based upon the terms of the option grant and the
    Company's stock price performance history as of the date of grant (May 24,
    1993). The key assumptions set forth below used in the valuation are based
    upon historical experience, and are not a forecast of future stock price
    performance or volatility or of future dividend policy. No adjustments
    have been made for forfeitures or nontransferability.
 
    Dividend Yield: 1.66%
    Volatility: 0.04148
    Risk-free Rate of Return: 5.930%
    Expected Exercise Period: 10 years
 
STOCK OPTION EXERCISES
 
  The following table contains information relating to the exercise of stock
options by the named executives in fiscal 1993 as well as the number and value
of their unexercised options as of September 30, 1993.
 
                  AGGREGATED OPTION/SAR EXERCISES IN 1993 AND
                       FISCAL YEAR-END OPTION/SAR VALUES
 
<TABLE>
<CAPTION>
                                                                             VALUE OF UNEXERCISED
                                     VALUE REALIZED  NUMBER OF UNEXERCISED       IN-THE-MONEY
                           SHARES     (MARKET VALUE    OPTIONS AT FISCAL    OPTIONS/SARS AT FISCAL
                          ACQUIRED      LESS ANY           YEAR-END                YEAR-END
    NAME                 ON EXERCISE EXERCISE PRICE) (ALL EXERCISABLE) (B) (ALL EXERCISABLE) (A)(B)
    ----                 ----------- --------------- --------------------- ------------------------
<S>                      <C>         <C>             <C>                   <C>
Raymond V. Gilmartin....    9,952       $288,671            421,800               $2,319,889
Clateo Castellini.......    2,000         52,785            184,000                  900,716
John W. Galiardo........   12,000        378,555            172,600                  856,629
Walter M. Miller........    6,000         86,557            154,738                  501,951
Robert A. Reynolds......    5,600        166,516            144,000                  665,421
</TABLE>
- --------
(A) The value of unexercised options represents the difference between the
    closing price of the Company's Common Stock on September 30, 1993
    ($37.625), and the exercise price of each unexercised option held by the
    named executives with an exercise price of less than $37.625.
 
(B) All option grants to the named executives are for a ten-year term. They
    are exercisable immediately, subject to applicable rules and regulations
    of the SEC. These option grants are issued in tandem with limited SARs,
    exercisable only in the event of a tender offer for the Company's Common
    Stock or a change in control of the Company, as defined under the
    Company's 1990 Stock Option Plan.
 
RETIREMENT PLAN
 
  The Company's Retirement Plan (the "Retirement Plan") is a non-contributory
defined benefit plan. It provides for normal retirement at age 65 and permits
earlier retirement in certain cases. Benefits are based upon years of service
and compensation (including salary, commissions, bonuses and stock award
distributions ("Covered Compensation")) for the five consecutive calendar
years which produce the highest average compensation ("Maximum Average
Compensation"). The Retirement Plan is integrated with Social Security.
 
  The Internal Revenue Code of 1986, as amended (the "Code") limits the
maximum annual benefit which may be paid to any individual from the Retirement
Plan's trust fund and the amount of compensation that may be recognized. Under
the Company's Retirement Benefit Restoration Plan (the "Restoration Plan"),
the Company will make supplemental, unfunded payments to offset any reductions
in benefits which may result from such limitations. The Company's obligations
to pay retirement benefits under the Restoration Plan and separate agreements
with certain key employees of the Company (including the named executives), as
well as deferred amounts under the Executive Bonus Plan, are secured by a
trust. The trust is currently secured by a letter of credit. The trustee is
required to draw on the letter of credit, up to specified limits, following a
change in control of the Company (as defined in the trust agreement).
 
                                      13
<PAGE>
 
  The table below shows the estimated annual retirement benefits payable under
the Retirement Plan and the Restoration Plan at normal retirement date to all
eligible employees, including the named executives, in specified remuneration
and years of service classifications.
 
                      ESTIMATED ANNUAL RETIREMENT BENEFITS
 
<TABLE>
<CAPTION>
  MAXIMUM                       YEARS OF CREDITED SERVICE
  AVERAGE     -------------------------------------------------------------
COMPENSATION     10      15       20       25       30       35       40
- ------------  -------- ------- -------- -------- -------- -------- --------
<S>           <C>      <C>     <C>      <C>      <C>      <C>      <C>
$  200,000    $ 28,916 $43,374 $ 57,832 $ 72,290 $ 86,748 $101,206 $115,664
   300,000      43,916  65,874   87,832  109,790  131,748  153,706  175,664
   400,000      58,916  88,374  117,832  147,290  176,748  206,206  235,664
   500,000      73,916 110,874  147,832  184,790  221,748  258,706  295,664
   600,000      88,916 133,374  177,832  222,290  266,748  311,206  355,664
   700,000     103,916 155,874  207,832  259,790  311,748  363,706  415,664
   800,000     118,916 178,374  237,832  297,290  356,748  416,206  475,664
   900,000     133,916 200,874  267,832  334,790  401,748  468,706  535,664
 1,000,000     148,916 223,374  297,832  372,290  446,748  521,206  595,664
 1,100,000     163,916 245,874  327,832  409,790  491,748  573,706  655,664
 1,200,000     178,916 268,374  357,832  447,290  536,748  626,206  715,664
 1,300,000     193,916 290,874  387,832  484,790  581,748  678,706  775,664
 1,400,000     208,916 313,374  417,832  522,290  626,748  731,206  835,664
</TABLE>
 
  Amounts shown are calculated on a straight life annuity basis, and are not
subject to any further deduction for Social Security benefits or other offsets.
Employees may elect to receive the actuarial value of their retirement benefits
in a lump sum in lieu of a lifetime pension.
     
  Under the Retirement Plan, years of credited service as of December 31, 1993
and Covered Compensation for the calendar year ended December 31, 1993 are 17
years and $1,101,200 for Mr. Gilmartin, 15 years and $546,761 for Mr.
Castellini, 16 years and $438,480 for Mr. Galiardo, 13 years and $356,568 for
Mr. Miller and 38 years and $397,064 for Mr. Reynolds.      
 
  In addition, employment agreements with the named executives (more fully
discussed below under "Contractual Obligations") provide for a supplemental
pension computed by assuming additional years of credited service for purposes
of calculating this benefit under the Retirement Plan in the event of
termination of employment under certain stated conditions. This calculation
would result in 11 additional years for Mr. Gilmartin, 15 additional years for
Mr. Castellini, 15 additional years for Mr. Galiardo, and 12 additional years
for Mr. Miller. These supplemental pension amounts would be offset by any
pensions payable from prior employers.
 
CONTRACTUAL OBLIGATIONS
 
  The named executives have employment agreements with the Company which
provide for continuation of their base salaries and fringe benefits for two
years after termination by the Company other than for cause or by the employee
for good reason not within three years following a change in control of the
Company. The terms "cause", "good reason" and "change in control" are defined
in the agreements. In the event of termination other than for cause or for good
reason within three years following a change in control, each named executive
would receive a payment equal to two times his highest aggregate annual
compensation (salary, bonus and stock award distributions) in any of the three
calendar years preceding the calendar year in which termination occurs, and his
fringe benefits, reduced to the extent provided by any subsequent employer,
would be continued for life. Had Messrs. Castellini, Galiardo, Gilmartin,
Miller and Reynolds been terminated on September 30, 1993 following a change in
control, they would have been entitled to cash payments of $870,131, $818,265,
$1,985,066, $852,785 and $734,309, respectively.
 
 
                                       14
<PAGE>
 
  In the event of termination other than for cause or for good reason within
three years following a change in control, the named executive would be
entitled to all of the pension benefits which he would have earned had he
remained an employee until age 65. If any termination payments to a named
executive pursuant to his agreement should be subject to the excise tax imposed
by Section 4999 of the Code (the "Excise Tax"), the Company would reimburse him
in an amount such that he would retain the same amount, net of all taxes, that
he would have retained had the Excise Tax not been in effect.
 
PERFORMANCE COMPARISON
   
  The following graph presents a comparison of cumulative total return to
shareholders for the five- year period ended September 30, 1993, for the
Company, the S&P 500 Index, and the S&P Medical Products and Supplies Stock
Price Index. This is the comparison period required by applicable rules and
regulations of the SEC. Cumulative total return to shareholders is measured by
dividing total dividends (assuming dividend reinvestment) plus per share price
change for the period by the share price at the beginning of the measurement
period. The Company's cumulative shareholder return is based on an investment
of $100 on September 30, 1988 and is compared to the cumulative total return of
the S&P 500 Index and the S&P Medical Products and Supplies Stock Price Index
over the same period with a like amount invested.     
 
  Companies measured in the S&P Medical Products and Supplies Stock Price
Index, in addition to the Company, are Allergan, Inc., C.R. Bard, Inc., Bausch
& Lomb, Inc., Baxter International Inc., Biomet, Inc., Medtronic, Inc. and St.
Jude Medical, Inc.
 
 
                            Performance Graph Data 

<TABLE> 
<CAPTION> 
                                                         S&P
Measurement Period           Becton         S&P          Medical Products &
Fiscal Year Covered          Dickinson      500 Index    Supplies Index
- -------------------          ----------     ---------    ------------------
<S>                          <C>            <C>          <C>  
Measurement Pt-
FYE  9/30/88                   $100.00        $100.00          $100.00
    12/31/88                   $ 91.27        $103.09          $ 97.88
     3/31/89                   $ 89.07        $110.40          $103.50
     6/30/89                   $101.64        $120.14          $113.70
FYE  9/30/89                   $101.86        $133.01          $124.82  
    12/31/89                   $110.57        $135.75          $134.25
     3/31/90                   $108.60        $131.67          $126.29
     6/30/90                   $126.36        $139.95          $142.71
FYE  9/30/90                   $118.96        $120.71          $133.71  
    12/31/90                   $135.32        $131.54          $157.53
     3/31/91                   $142.65        $150.64          $196.64
     6/30/91                   $136.12        $150.30          $189.68
FYE  9/30/91                   $124.98        $158.34          $209.76  
    12/31/91                   $126.45        $171.61          $257.57
     3/31/92                   $130.70        $167.28          $217.70
     6/30/92                   $138.67        $170.46          $216.58
FYE  9/30/92                   $140.39        $175.83          $204.16  
    12/31/92                   $147.55        $184.69          $220.71
     3/31/93                   $137.14        $192.75          $192.47
     6/30/93                   $151.43        $193.69          $177.67
FYE  9/30/93                   $143.07        $198.17          $154.73  

</TABLE> 

                                      15
<PAGE>
 
PROPOSAL 2.            SELECTION OF INDEPENDENT AUDITORS
 
  The Board of Directors, pursuant to the recommendation of the Audit
Committee, has selected Ernst & Young to audit the accounts of the Company and
its subsidiaries for the fiscal year ending September 30, 1994. A
representative of Ernst & Young will attend the Annual Meeting to respond to
appropriate questions and will have the opportunity to make a statement.
 
  The Board of Directors recommends a vote FOR approval of the selection of
Ernst & Young. If approval is withheld, the Board will reconsider its
selection.
 
PROPOSAL 3.          APPROVAL OF 1994 RESTRICTED STOCK PLAN
                           FOR NON-EMPLOYEE DIRECTORS
 
  In December 1993, the Board of Directors adopted the 1994 Restricted Stock
Plan for Non-Employee Directors (the "Plan"), subject to shareholder approval.
The Board believes the Plan will further the growth, development and financial
success of the Company by enabling the Company to attract and retain non-
employee directors of outstanding ability and by linking a portion of their
compensation to the enhancement of the Company's stock value.
 
  A brief description of the material provisions of the Plan is as follows:
 
    1. Issuable Shares. There will be reserved 75,000 shares of the Company's
  Common Stock for issuance pursuant to the Plan, subject to adjustment for
  stock dividends, stock splits or other issuances of stock without
  consideration.
 
    2. Participation. Plan participation is limited to members of the Board
  who are not employees of the Company or any of its subsidiaries.
 
    3. Acquisitions of Restricted Stock. The quarterly retainer payable each
  April 30th to non-employee directors will be paid in shares of restricted
  Common Stock in lieu of cash. In addition, participants in the Plan may
  elect to have one or more of their remaining quarterly retainer payments
  paid in shares of restricted stock rather than in cash. Participants will
  also have a one-time opportunity to acquire shares of restricted stock with
  their previously deferred director's fees.
 
    4. Restrictions. Restricted shares cannot be sold, assigned or pledged
  until the restrictions on the shares lapse. During the restricted period,
  the participant will have all of the other rights of a shareholder with
  respect to restricted shares acquired under the Plan, including voting
  rights and the rights to receive dividends. The restrictions on restricted
  shares will lapse upon the applicable "Vesting Date" (as defined below) or
  earlier, upon the occurrence of any of the following: (1) termination of a
  participant's service on the Board due to death, disability or retirement
  in accordance with the policy on retirement of non-employee directors; (ii)
  removal from the Board following a "change in control" (as defined in the
  Plan); (iii) resignation from the Board due to a conflict of interest; (iv)
  financial hardship; (v) failure to be renominated for Board service other
  than due to the participant's refusal or failure to stand for such
  renomination; or (vi) failure to be re-elected after being duly nominated.
  The "Vesting Date" shall be the date the participant's then-current term of
  service on the Board expires, or such later date as may be selected by the
  participant in accordance with the terms of the Plan.
 
    5. Forfeiture. All of a participant's restricted shares will be forfeited
  to the Company if the participant's service on the Board terminates for a
  reason other than those set forth in item 4 above.
 
    6. Administration. The Plan will be administered by the Compensation and
  Benefits Committee of the Board or such other committee as may be
  designated by the Board.
 
  Since the shares to be issued under the Plan will be issued in lieu of
certain of the retainer and previously deferred director fees that would
otherwise be payable by the Company to its non-employee directors, the adoption
of the Plan will not result in additional benefit payments by the Company. If
the Plan had been in effect during the fiscal year ended September 30, 1993,
the Company's non-employee
 
                                       16
<PAGE>
 
directors would have received an aggregate of 3,168 restricted shares under the
Plan in lieu of the April 30 quarterly retainer payments. In addition, the
Company's non-employee directors would have been eligible to elect to receive
an aggregate of 8,756 restricted shares and 15,592 restricted shares under the
Plan in lieu of their remaining quarterly retainer fees and previously deferred
directors' fees, respectively.
 
  THE FOREGOING SUMMARY OF THE PLAN IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO THE PROVISIONS OF THE PLAN, A COPY OF WHICH IS ATTACHED AS EXHIBIT A TO THIS
PROXY STATEMENT.
 
            THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSAL 3.
 
PROPOSAL 4.                  SHAREHOLDER'S PROPOSAL
 
                     DISCLOSURE OF POLITICAL CONTRIBUTIONS
 
  Mrs. Evelyn Y. Davis, Watergate Office Building, 2600 Virginia Avenue N.W.,
Suite 215, Washington D.C. 20037, owner of 100 shares of Common Stock, has
informed the Company that she plans to introduce the following resolution at
the meeting:
 
    "RESOLVED: That the shareholders recommend that the Board direct
  management that within five days after approval by the shareholders of this
  proposal, the management shall publish in newspapers of general circulation
  in the cities of New York, Washington, D.C., Detroit, Chicago, San
  Francisco, Los Angeles, Dallas, Houston and Miami, and in the Wall Street
  Journal and U.S.A. Today, a detailed statement of each contribution made by
  the Company, either directly or indirectly, within the immediately
  preceding fiscal year, in respect of a political campaign, political party,
  referendum or citizens' initiative, or attempts to influence legislation,
  specifying the date and amount of each such contribution, and the person or
  organization to whom the contribution was made. Subsequent to this initial
  disclosure, the management shall cause like data to be included in each
  succeeding report to shareholders. And if no such disbursements were made,
  to have that fact publicized in the same manner."
 
  The shareholder's statement in support of this resolution is as follows:
 
    "REASONS: This proposal, if adopted, would require the management to
  advise the shareholders how many corporate dollars are being spent for
  political purposes and to specify what political causes the management
  seeks to promote with those funds. It is therefore no more than a
  requirement that the shareholders be given a more detailed accounting of
  these special purpose expenditures than they now receive. These political
  contributions are made with dollars that belong to the shareholders as a
  group and they are entitled to know how they are being spent.
 
    "Last year the owners of 2,387,297 shares, representing approximately
  8.3% of shares voting, voted FOR this proposal.
 
    If you AGREE, please mark your proxy FOR this resolution."
 
THE BOARD OF DIRECTORS RECOMMENDS A VOTE AGAINST PROPOSAL 4.
 
  Under applicable law, the Company makes no corporate contributions to Federal
candidates and only insignificant contributions to state candidates. The
Company and its operating units do, however, participate in business-oriented
political and civic activities, and make their positions known on legislation
that is significant to their businesses. The Company believes that these are
important efforts, which should not be hindered by special disclosure rules
that do not apply to others and that would impose an unnecessary expense upon
the Company.
 
SHAREHOLDER PROPOSALS FOR 1995 ANNUAL MEETING
 
  Shareholder proposals for the 1995 Annual Meeting must be received at the
principal executive offices of the Company, 1 Becton Drive, Franklin Lakes, New
Jersey 07417-1880, not later than September 1, 1994 for inclusion in the proxy
statement and form of proxy.
 
                                    * * * *
 
                                       17
<PAGE>
 
                                                                       EXHIBIT A
 
                         BECTON, DICKINSON AND COMPANY
 
             1994 RESTRICTED STOCK PLAN FOR NON-EMPLOYEE DIRECTORS
 
SECTION 1. PURPOSE
 
  The purpose of this 1994 Restricted Stock Plan for Non-Employee Directors
(the "Plan") is to further the growth, development and financial success of
Becton, Dickinson and Company (the "Company") by enabling the Company to
attract and retain non-employee directors of outstanding ability and by linking
a portion of their compensation to the enhancement of the Company's stock
value.
 
SECTION 2. DEFINITIONS
 
  Capitalized terms used in this Plan and not defined above shall have the
meanings set forth in this Section 2.
 
    (a) "Board" shall mean the Board of Directors of the Company.
 
    (b) "Change in Control" shall mean and be deemed to have occurred if (i)
  any "person" (as such term is used in Sections 13(d) and 14(d) of the
  Exchange Act), other than a trustee or other fiduciary holding securities
  under an employee benefit plan of the Company or a corporation owned,
  directly or indirectly, by the stockholders of the Company in substantially
  the same proportions, becomes the "beneficial owner" (as defined in Rule
  13d-3 under the Exchange Act), directly or indirectly, of securities of the
  Company representing twenty-five percent (25%) or more of the combined
  voting power of the Company's then-outstanding securities; or (ii) during
  any period of two consecutive years individuals who at the beginning of
  such period constitute the Board and any new director whose election by the
  Board or nomination for election by the Company's stockholders was approved
  by a vote of at least two-thirds (2/3) of the directors then still in
  office who either were directors at the beginning of the period or whose
  election or nomination for election was previously so approved, cease for
  any reason to constitute a majority thereof; or (iii) substantially all the
  assets of the Company are disposed of by the Company pursuant to a merger,
  consolidation, partial or complete liquidation, a sale of assets (including
  stock of a Subsidiary) or otherwise, but not including a reincorporation or
  similar transaction resulting in a change only in the form of ownership of
  such assets.
 
    (c) "Code" shall mean the Internal Revenue Code of 1986, as amended.
 
    (d) "Committee" shall mean the Compensation and Benefits Committee of the
  Board or such other committee as may be designated by the Board.
 
    (e) "Deferred Compensation" shall mean the amounts credited to the
  account of an Eligible Director pursuant to any Deferred Compensation
  Agreement.
 
    (f) "Deferred Compensation Agreement" shall mean any written agreement by
  and between an Eligible Director and the Company pursuant to which an
  Eligible Director may defer receipt of Director's Fees and other
  compensation for service as a member of the Board or any committee thereof.
 
    (g) "Director" shall mean a member of the Board.
 
    (h) "Director's Fees" shall mean the Board retainer fees payable to a
  Director and shall exclude Committee Chairman fees, any attendance fees for
  committee or special meetings and any other Director compensation.
 
    (i) "Eligible Director" shall mean a Director who is not also an
  "employee" of the Company (or its Subsidiaries) within the meaning of
  ERISA.
 
                                      A-1
<PAGE>
 
    (j) "ERISA" shall mean the Employee Retirement Income Security Act of
  1974, as amended.
 
    (k) "Exchange Act" shall mean the Securities Exchange Act of 1934, as
  amended.
 
    (l) "Fair Market Value" shall mean on the applicable date the mean of the
  highest and lowest selling prices of the Stock as reported on the Composite
  Tape for securities traded on the New York Stock Exchange or, if no selling
  prices are reported on such date, the date immediately prior thereto on
  which such selling prices are reported.
 
    (m) "Immediate and Severe Financial Hardship" shall mean an immediate and
  severe financial hardship resulting from a sudden and unexpected illness or
  accident of the Eligible Director or the Eligible Director's spouse or
  dependents, or from a loss of an Eligible Director's property due to
  casualty or other similar extraordinary and unforeseeable circumstances
  arising as a result of events beyond the control of the Eligible Director.
  The foregoing shall be interpreted narrowly and encompass circumstances
  determined to be an immediate and severe financial hardship to the average
  person.
 
    (n) "Payment Dates" shall mean the last days of January, April, July and
  October of each calendar year on which Director's Fees earned during the
  immediately preceding three (3) month period are payable.
 
    (o) "Restricted Shares" shall mean shares of Stock acquired by Eligible
  Directors pursuant to the Plan which are subject to the restrictions set
  forth in Section 9.
 
    (p) "Stock" shall mean the Common Stock, par value $1.00 per share, of
  the Company.
 
    (q) "Subsidiary" shall mean any subsidiary corporation of the Company as
  defined in Section 424 of the Code.
 
    (r) "Term of Service" shall mean the period commencing on the date an
  Eligible Director is elected and qualified to serve on the Board and ending
  on the date of the Annual Meeting of Shareholders of the Company for the
  year in which his term is due to expire.
 
    (s) "Vesting Date" shall have the meaning set forth in Section 10.
 
SECTION 3. ELIGIBILITY FOR PARTICIPATION IN THE PLAN
 
  Participation in the Plan is limited to Eligible Directors, all of whom will
be participants in the Plan.
 
SECTION 4. SHARES OF STOCK SUBJECT TO THE PLAN
 
  Subject to adjustment pursuant to Section 15, an aggregate of 75,000 shares
of Stock shall be reserved for issuance pursuant to the Plan. Shares delivered
under the Plan may be authorized and unissued shares or issued shares held by
the Company in its treasury.
 
SECTION 5. ADMINISTRATION OF THE PLAN
 
  The Plan shall be administered by the Committee. Subject to the express
provisions of the Plan, the Committee shall have authority to interpret the
Plan, to prescribe, amend and rescind rules and regulations relating to it and
to make all other determinations necessary or advisable for the administration
of the Plan. Any controversy or claim arising out of or related to the Plan
shall be determined unilaterally by and at the sole discretion of the Committee
and shall be final and binding on the Company and on the Eligible Directors.
 
SECTION 6. MANDATORY ACQUISITIONS OF RESTRICTED SHARES
 
  In lieu of receiving the Director's Fees otherwise payable on each April
Payment Date in cash, each Eligible Director shall acquire on such Payment Date
a number of Restricted Shares equal to the amount of such Director's Fees
divided by the Fair Market Value of the Stock on such April Payment Date.
 
                                      A-2
<PAGE>
 
SECTION 7. VOLUNTARY ACQUISITIONS OF RESTRICTED SHARES
 
    (a) Each Eligible Director may elect with respect to the Directors's Fees
  otherwise payable to the Eligible Director on any July, October and January
  Payment Date, to acquire on such Payment Date a number of Restricted Shares
  equal to the amount of such Director's Fees divided by the Fair Market
  Value of the Stock on such Payment Date.
 
    (b) Each Eligible Director may make a single irrevocable election prior
  to January 1, 1994 to have a stated percentage (increments of ten percent
  (10%)) of the Eligible Director's Deferred Compensation used to acquire on
  July 1, 1994 a number of Restricted Shares equal to the amount of the
  Deferred Compensation elected to be converted into Restricted Shares
  divided by the Fair Market Value of the Stock on July 1, 1994.
 
    (c) Any elections to acquire Restricted Shares pursuant to this Section
  7, and any modifications of any elections made pursuant to Section 7(a),
  (i) shall be in writing in the form prescribed by the Secretary of the
  Company, and (ii) must be delivered to the Secretary of the Company at
  least six months prior to the effective date of the transaction to which
  each such election or modification relates.
 
SECTION 8. ISSUANCE, POSSESSION AND DELIVERY OF RESTRICTED SHARES
 
    (a) Each acquisition of Restricted Shares under the Plan shall be
  evidenced by the issuance of a Stock certificate registered on the transfer
  ledgers of the Company in the name of the Eligible Director who acquired
  the Restricted Shares effective as of the date such Restricted Shares are
  acquired by the Eligible Director pursuant to the Plan. Each such
  certificate shall bear an appropriate legend referring to the restrictions
  applicable to the Restricted Shares.
 
    (b) Possession of any certificates representing Restricted Shares shall
  be retained by the Company for the benefit of each Eligible Director until
  the restrictions thereon have lapsed and been removed in accordance with
  Section 11. Thereupon, the Company shall promptly deliver the certificates
  for such shares to the Eligible Director.
 
    (c) Notwithstanding any other provision of the Plan, the issuance or
  delivery of any such shares of Stock may be postponed for such period as
  may be required to comply with any applicable requirements of any national
  securities exchange or any requirements under any other law or regulation
  applicable to the issuance or delivery of such shares. The Company shall
  not be obligated to issue or deliver any such shares if the issuance or
  delivery thereof shall constitute a violation of any provision of any law
  or of any regulation of any governmental authority or any national
  securities exchange.
 
SECTION 9. RESTRICTIONS ON RESTRICTED SHARES
 
  Unless and until the provisions of the Plan relating to removal of
restrictions have been satisfied, the Restricted Shares may not be sold,
assigned, pledged, encumbered, hypothecated or transferred other than pursuant
to a "qualified domestic relations order" within the meaning of ERISA.
 
SECTION 10. VESTING DATE
 
    (a) The Vesting Date for all Restricted Shares to be acquired by an
  Eligible Director during any Term of Service on the Board shall be the
  later of: (i) the date on which such Term of Service expires, or (ii) the
  calendar date selected by the Eligible Director in accordance with Section
  10(b).
 
    (b) On or before December 31, 1993, and thereafter within thirty (30)
  days following the commencement of each new Term of Service on the Board,
  each Eligible Director may select a single Vesting Date for all Restricted
  Shares to be acquired by the Eligible Director during the Eligible
  Director's then-current Term of Service.
 
    (c) All elections pursuant to this Section 10 shall be irrevocable for
  the applicable Term of Service on the Board and shall be in writing in the
  form prescribed by the Secretary of the Company.
 
                                      A-3
<PAGE>
 
SECTION 11. REMOVAL OF RESTRICTIONS
 
  The restrictions on the Restricted Shares set forth in Section 9 shall be
removed and lapse upon the applicable Vesting Date, or, if earlier, upon the
occurrence of any of the following:
 
    (a) the death of the Eligible Director;
 
    (b) the disability of the Eligible Director requiring discontinuance of
  service on the Board;
 
    (c) the retirement of the Eligible Director from service as a Director in
  accordance with the policy on retirement of non-employee Directors then in
  effect;
 
    (d) removal of the Eligible Director from the Board following a Change in
  Control;
 
    (e) resignation of the Eligible Director from the Board after furnishing
  an opinion of counsel, reasonably satisfactory to a majority of the
  Committee (other than the Eligible Director), to the effect that continued
  membership on the Board will result in the Eligible Director having a
  conflict of interest or suffering some other significant legal liability;
 
    (f) a determination by a majority of the Committee (other than the
  Eligible Director) that the Eligible Director has an Immediate and Severe
  Financial Hardship which cannot be met through any other means, limited to
  the number of Restricted Shares necessary to meet that hardship;
 
    (g) the failure of the Eligible Director to be renominated for Board
  service other than due to the Eligible Director's refusal or failure to
  stand for such renomination; or
 
    (h) the failure of the Eligible Director to be re-elected after being
  duly nominated.
 
  The foregoing notwithstanding, Restricted Shares acquired pursuant to Section
6 shall remain subject to the restrictions set forth in Section 9 for at least
six months following the date of such acquisition.
 
SECTION 12. RIGHTS AS A SHAREHOLDER
 
  Subject to the restrictions set forth in the Plan, an Eligible Director shall
be entitled to all of the rights of a shareholder with respect to the
Restricted Shares from the date such shares are acquired pursuant to the Plan,
including voting rights and the rights to receive dividends and other
distributions. All shares of Stock or other securities paid on Restricted
Shares shall be held by the Company and shall be subject to the same
restrictions as the Restricted Shares to which they relate.
 
SECTION 13. FORFEITURE
 
  An Eligible Director's Restricted Shares shall be forfeited to the Company
upon the Eligible Director's termination of service on the Board for any reason
other than those set forth in Section 11.
 
SECTION 14. FRACTIONAL SHARES
 
  The Company shall promptly pay to an Eligible Director the cash equivalent of
any fractional shares which would otherwise be acquired by the Eligible
Director under the terms of the Plan.
 
SECTION 15. ADJUSTMENTS
 
  There shall be proportionate adjustments of the aggregate number of shares of
Stock reserved for issuance under the Plan, in the event of an increase in the
number of issued shares of Stock by reason of any stock dividend, stock split-
up or other issuance of shares without consideration.
 
  No exercise of conversion rights with respect to the shares of the Company's
Series B ESOP Convertible Preferred Stock shall call for any adjustment under
this Section 15.
 
                                      A-4
<PAGE>
 
SECTION 16. GENERAL PROVISIONS
 
    (a) It is intended that the Plan and any transaction involving a person
  subject to Section 16 of the Exchange Act meet all of the requirements of
  Rule 16b-3, promulgated by the Securities and Exchange Commission, as such
  rule is currently in effect or as hereafter modified or amended. If any
  provision of the Plan or any transaction would disqualify the Plan or such
  transaction under, or would not comply with, Rule 16b-3, such provision or
  transaction shall be construed or deemed amended to conform to Rule 16b-3
  or otherwise shall be deemed to be null and void, in each case to the
  extent permitted by law and deemed advisable by the Committee.
 
    (b) Nothing in the Plan shall confer upon any Eligible Director any right
  to serve as a member of the Board for any period of time or to continue at
  the present or any other rate of compensation.
 
SECTION 17. AMENDMENT AND TERMINATION
 
    (a) The Board may amend or terminate the Plan at any time without notice;
  provided however, that the Board may not, without prior approval by the
  shareholders, (i) materially increase the maximum number of shares of Stock
  which may be issued under the Plan (except as contemplated by the
  provisions of Section 15), (ii) materially increase the benefits accruing
  to participants under the Plan, (iii) materially modify the requirements as
  to eligibility for participation in the Plan, or (iv) accelerate the
  removal and lapse of the restrictions set forth in Section 9 on Restricted
  Shares acquired by an Eligible Director prior to the date of such
  amendment.
 
    (b) The provisions of the Plan which govern eligibility to participate
  and the amount, price and timing of the mandatory acquisitions of
  Restricted Shares pursuant to Section 6 shall not be amended more than once
  every six months, other than to comply with changes in the Code, ERISA or
  the rules thereunder.
 
    (c) No termination or amendment of the Plan may adversely affect any
  Eligible Director's rights with respect to Restricted Shares which were
  acquired by such Eligible Director prior to such action.
 
SECTION 18. EFFECTIVE DATE AND SHAREHOLDERS' APPROVAL
 
  The Plan shall become effective upon approval by the affirmative votes of the
holders of a majority of the shares present, or represented, and entitled to
vote thereon at the February 8, 1994 Annual Meeting of Shareholders of the
Company or any adjournment or postponement thereof.
 
 
                                      A-5
<PAGE>
        

                    GRAPHIC MATERIAL CROSS-REFERENCE PAGE


    PHOTOS OF THE DIRECTORS AND NOMINEES FOR DIRECTORS APPEAR TO THE LEFT 
    OF EACH RESPECTIVE NAME ON PAGES 5, 6 AND 7.


    A PERFORMANCE GRAPH SHOWING A COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL
    RETURN AMONG BECTON, DICKINSON AND COMPANY, S&P 500 INDEX AND S&P MEDICAL
    PRODUCTS & SUPPLIES INDEX APPEARS ON PAGE 15. (THE NUMBERS USED IN GRAPH
    APPEAR ON PAGE 15.) 



<PAGE>
                                          
                                             

                         PROXY/VOTING INSTRUCTION CARD
                         BECTON, DICKINSON AND COMPANY
            PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS FOR
                      ANNUAL MEETING ON FEBRUARY 8, 1994
 
The undersigned hereby appoints Raymond V. Gilmartin, John W. Galiardo and
Raymond P. Ohlmuller, and any of them, with full power of substitution, proxies
to attend the annual meeting of the shareholders of the Company to be held at
2:30 P.M. on Tuesday, February 8, 1994, at the Marriott Hotel, Garden State
Parkway at Interstate 80, Saddle Brook, New Jersey, and any adjournment
thereof, and to vote all shares of the Common Stock of the Company which the
undersigned is entitled to vote upon each of the matters referred to in this
proxy and, in their discretion, upon such other matters as may properly come
before the meeting.
 
This card constitutes voting instructions to the Trustee for any shares of
Common Stock and Series B ESOP Convertible Preferred Stock allocated to the
undersigned under the Company's Savings Incentive Plan.
 
     Election of Directors to Terms of Three Years:
 
     Nominees:
      Harry N. Beaty, M.D., Raymond V. Gilmartin, Frank A. Olson
 
YOU ARE ENCOURAGED TO SPECIFY YOUR CHOICES BY MARKING THE APPROPRIATE
BOXES, SEE REVERSE SIDE, BUT YOU NEED NOT MARK ANY BOXES IF YOU WISH TO VOTE
IN ACCORDANCE WITH THE BOARD OF DIRECTORS' RECOMMENDATIONS. PLEASE SIGN AND 
RETURN THIS CARD USING THE ENCLOSED ENVELOPE.
 
                                          CONTINUED, AND 
                                          TO BE SIGNED,
                                          ON REVERSE SIDE
 
 
<PAGE>
 
 
 
/X/  PLEASE MARK YOUR                                                 1508
     VOTES AS IN THIS
     EXAMPLE.
 
 
 
THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN.
IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR ELECTION OF DIRECTORS,
FOR PROPOSALS 2 AND 3 AND AGAINST PROPOSAL 4.

- ---------------------------------------------------------------------
   THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSALS 1, 2 AND 3.
- ---------------------------------------------------------------------
 
1. Election of                                 FOR              WITHHELD
   Directors. (see reverse)                    / /                 / /

For, except vote withheld from the following nominee(s):


- --------------------------------------------------------


2. Approval of Independent auditors.     FOR          AGAINST       ABSTAIN
                                         / /            / /           / /
 
3. Approval of 1994 Restricted Stock     / /            / /           / /
   Plan for Non-Employee Directors.
- ------------------------------------------------------------------------------- 
 
 
- ------------------------------------------------------------------------------- 
          THE BOARD OF DIRECTORS RECOMMENDS A VOTE AGAINST PROPOSAL 4.
- ------------------------------------------------------------------------------- 
 
 4. Disclosure of political              FOR          AGAINST       ABSTAIN
    contributions.                       / /            / /           / /
 
- ------------------------------------------------------------------------------- 



NOTE: Please sign exactly as name appears hereon. Joint owners should each
      sign. When signing as attorney, executor, administrator, trustee or 
      guardian, please give full title as such.



- -----------------------------------------------

- -----------------------------------------------
SIGNATURE(S)                           DATE
 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission